FDA 483 Finds Deficiencies at Baxter Healthcare Facility
FDA’s San Juan district office has found numerous problems at a Baxter sterile drug manufacturing facility in Jayuya, Puerto Rico following a series of inspections in late August through early October.
Source: Drug GMP Report